BHST

BioHarvest Sciences Inc.

6.18

Top Statistics
Market Cap 0.0000 Forward PE 38.60 Revenue Growth 119.20 %
Current Ratio 1.03 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -84.84 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -15.86 Enterprise / Revenue 5.98 Price To Sales Trailing12 Months
Profitability
Profit Margins -84.84 % Operating Margins -29.47 %
Balance Sheet
Total Cash 5 M Total Cash Per Share 0.2980 Total Debt 10 M
Total Debt To Equity 155.00 Current Ratio 1.03 Book Value Per Share -1.09
All Measures
Message Board Id finmb_228618557 Fax 604 685 9182 Return On Equity -59.56
City Vancouver Uuid 4805938b-3300-3b8f-86bd-8cf6aa200f39 Previous Close 6.01
First Trade Date Epoch Utc 1 B Book Value -1.09 Beta 1.49
Total Debt 10 M Volume 5637 Fifty Two Week Low 0.0010
Total Cash Per Share 0.2980 Total Revenue 19 M Target Median Price 18.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -29.47 %
Target Mean Price 18.00 Net Income To Common -16230000 Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 15990 Average Volume10days 15990
Total Cash 5 M Next Fiscal Year End 1 B Revenue Per Share 1.33
Held Percent Insiders 0.2585 Ebitda Margins -37.71 % Trailing PE 0.0000
Most Recent Quarter 1 B Regular Market Previous Close 6.01 Target Low Price 18.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 5.48 Open 6.50
Free Cashflow -5958625 State BC Dividend Yield 0.00 %
Return On Assets -0.2583 Time Zone Short Name EST Day Low 6.00
Address1 1140-625 Howe Street Target High Price 18.00 Price Hint 2
Website https://www.bioharvest.com 52 Week Change 42.49 Average Volume 5448
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 74.80 % Is_sp_500 False Regular Market Day High 6.50
Profit Margins -84.84 % Debt To Equity 155.00 Fifty Two Week High 7.38
Day High 6.50 Regular Market Open 6.50 Earnings Growth 0.00 %
Enterprise To Revenue 5.98 Revenue Growth 119.20 % Operating Cashflow -6525000
Currency USD Time Zone Full Name America/New_York Is_nasdaq_100 False
Market Cap 0.0000 Zip V6C 2T6 Quote Type EQUITY
Long Name BioHarvest Sciences Inc. Regular Market Day Low 6.00 Current Price 6.18
Enterprise To Ebitda -15.86 Financial Currency USD Current Ratio 1.03
Gross Margins 51.44 % Number Of Analyst Opinions 1 Country Canada
Float Shares 12 M Two Hundred Day Average 3.61 Enterprise Value 114 M
Forward PE 38.60 Regular Market Volume 5637 Ebitda -7214000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha
BioHarvest Sciences Inc. operates as a biotechnology company.

The company operates through Nutraceuticals and Pharmaceuticals segments.

It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.

The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals.

It also operates as a contract development and manufacturing operation services.

In addition, the company offers wellness products.

Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes.

The company operates in Israel and the United States.

BioHarvest Sciences Inc. is based in Vancouver, Canada.